FDA.reportPublic FDA data

LOTEMAX 0.5 % Ophthalmic Gel

RxCUI
1312627
RxNorm name
LOTEMAX 0.5 % Ophthalmic Gel
Display name
LOTEMAX 0.5 % Ophthalmic Gel
Full name
LOTEMAX 0.5 % Ophthalmic Gel
Term type
PSN
Status
DailyMed mapping
Updated
2026-06-04 23:39:10

RxNav Current And Historical NDCs#

RxNav current and historical NDC rows page 1 of 1 · 0 matching rows.

No records found.

UNII Substances#

UNII substance links page 1 of 1 · 0 matching rows.

No records found.

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 1 matching rows.

Brand, Generic, Manufacturer table
BrandGenericManufacturerSPL set IDEffective dateAvailable safety fieldsJoin
LOTEMAXLOTEPREDNOL ETABONATEBausch & Lomb Incorporated9a666065-d467-42b8-8ecd-0ec1de9986d52024-10-24Warnings, Adverse reactionsExact identifier
rxcui: 1312627

DailyMed RxNorm Mappings#

unique DailyMed labels mapped to this RxNorm concept page 1 of 1 · 1 matching rows.

Set ID, RxNorm mappings, Terms table
Set IDRxNorm mappingsTermsSPL versionLabelEffective
9a666065-d467-42b8-8ecd-0ec1de9986d5LOTEMAX 0.5 % Ophthalmic Gel [PSN] · loteprednol etabonate 0.005 MG/MG Ophthalmic Gel [Lotemax] [SBD] · Lotemax 0.005 MG/MG Ophthalmic Gel [SY] · Lotemax 0.5 % Ophthalmic Gel [SY]412These highlights do not include all the information needed to use LOTEMAX safely and effectively. See full prescribing information for LOTEMAX. LOTEMAX ® (loteprednol etabonate ophthalmic gel), for topical ophthalmic use Initial U.S. Approval: 199820241024